Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Dermatology
•
General Dermatology
Do you feel there is any role for neoadjuvant imatinib in pediatric DFSP with the classic translocation given that surgery can introduce high morbidity?
Related Questions
How do you manage severe chronic scalp pruritus in older women when biopsies and exams show no primary skin disease and standard therapies fail?
Is there a role for patients who have a strong familial history of HS to receive a genetics evaluation or referral to clinical trials?
How often, and why, do you complete disability forms for dermatologic patients?
What should be done for a patient with biopsy-proven seborrheic dermatitis on the scalp and central forehead (presenting as a large annular scaly thin plaque) who has failed treatment with fluconazole, antifungal creams, and Zoryve (which is too expensive)?
For patients with xanthelasma, aside from a lipid panel, do you perform any additional lab workup or send referrals?
How have you used GLP1s in dermatology?
What are your preferred alternative biologic agents for Blau Syndrome when anti-TNFα therapies are contraindicated?
Would you start glycopyrrolate in elderly population and how do you counsel the patient?
What is your diagnostic and treatment approach for patients hospitalized with erythroderma?
How do you approach patients who continue to experience pruritus and ongoing concern for persistent scabies despite having completed appropriate treatment?
